keyword
Keywords "Personalized medicine" dispar...

"Personalized medicine" disparities

https://read.qxmd.com/read/36983665/a-gender-based-point-of-view-in-pediatric-neurology
#41
REVIEW
Pierluigi Diana, Susanna Esposito
While the significance of gender has only recently been recognized, gender assigned at birth has long been understood to have a significant influence on a number of illnesses. Due to the paucity of data in this regard in pediatrics, the purpose of this narrative review is to frame the most recent knowledge about the role of gender assigned at birth in the neurological development and neuropsychiatric disorders among young people. Literature analysis showed that gender disparities exist in neurologic and neuropsychiatric disorders among the pediatric population and supported the fact that new guidelines should take this into account...
March 8, 2023: Journal of Personalized Medicine
https://read.qxmd.com/read/36983663/the-impact-of-the-need-for-language-assistance-services-on-the-use-of-regional-anesthesia-postoperative-pain-scores-and-opioid-administration-in-surgical-oncology-patients
#42
JOURNAL ARTICLE
Ravish Kapoor, Pascal Owusu-Agyemang, Lei Feng, Juan P Cata
Language barriers can negatively impact the quality of healthcare. In surgical patients, limited English proficiency (LEP) can lead to disparities in acute postoperative pain management. Interpreters are often used for communication with LEP patients to help alleviate these disparities. We aimed to investigate the impact of the need for language assistance services (LAS) in acute postoperative pain management in patients undergoing oncologic surgery. We retrospectively collected data on adult patients undergoing open abdominal oncologic surgery between March 2016 and August 2021...
March 7, 2023: Journal of Personalized Medicine
https://read.qxmd.com/read/36983622/direct-mechanical-thrombectomy-vs-bridging-therapy-in-stroke-patients-in-a-stroke-belt-region-of-southern-europe
#43
JOURNAL ARTICLE
Cristina Del Toro-Pérez, Laura Amaya-Pascasio, Eva Guevara-Sánchez, María Luisa Ruiz-Franco, Antonio Arjona-Padillo, Patricia Martínez-Sánchez
The aim of this 4-year observational study is to analyze the outcomes of stroke patients treated with direct mechanical thrombectomy (dMT) compared to bridging therapy (BT) (intravenous thrombolysis [IVT] + BT) based on 3-month outcomes, in real clinical practice in the "Stroke Belt" of Southern Europe. In total, 300 patients were included (41.3% dMT and 58.6% BT). The frequency of direct referral to the stroke center was similar in the dMT and BT group, whereas the time from onset to groin was longer in the BT group (median 210 [IQR 160-303] vs...
February 28, 2023: Journal of Personalized Medicine
https://read.qxmd.com/read/36836558/advancing-osteoporosis-evaluation-procedures-detailed-computational-analysis-of-regional-structural-vulnerabilities-in-osteoporotic-bone
#44
JOURNAL ARTICLE
Matthew A Wysocki, Scott T Doyle
Osteoporotic fractures of the femur are associated with poor healing, disability, reduced quality of life, and high mortality rates within 1 year. Moreover, osteoporotic fractures of the femur are still considered to be an unsolved problem in orthopedic surgery. In order to more effectively identify osteoporosis-related fracture risk and develop advanced treatment approaches for femur fractures, it is necessary to acquire a greater understanding of how osteoporosis alters the diaphyseal structure and biomechanical characteristics...
February 13, 2023: Journal of Personalized Medicine
https://read.qxmd.com/read/36836429/laboratory-findings-and-clinical-outcomes-of-icu-admitted-covid-19-patients-a-retrospective-assessment-of-particularities-identified-among-romanian-minorities
#45
JOURNAL ARTICLE
Alexandra Mocanu, Voichita Elena Lazureanu, Ruxandra Laza, Adelina Raluca Marinescu, Talida Georgiana Cut, Suzana-Vasilica Sincaru, Adina Maria Marza, Irina-Maria Popescu, Lucian-Flavius Herlo, Andreea Nelson-Twakor, Mircea Rivis, Felix Bratosinand, Tamara Mirela Porosnicu, Alexandru Ovidiu Mederle
The Roma population accounts for over 3% (approximately 10 to 15 million) of Romania's permanent population, and it represents one of Europe's most impoverished populations. Due to poverty and unemployment, Romania's Roma minority may have diminished access to healthcare and preventive medicine. The limited existing evidence suggests that the European Roma group has been at a higher risk of becoming ill and dying during the pandemic owing to their lifestyle choices, socioeconomic circumstances, and genetic pathophysiological traits...
January 21, 2023: Journal of Personalized Medicine
https://read.qxmd.com/read/36835811/overcoming-barriers-to-tobacco-cessation-and-lung-cancer-screening-among-racial-and-ethnic-minority-groups-and-underserved-patients-in-academic-centers-and-community-network-sites-the-city-of-hope-experience
#46
JOURNAL ARTICLE
Cary A Presant, Kimlin Ashing, Dan Raz, Sophia Yeung, Brenda Gascon, Alexis Stewart, Jonjon Macalintal, Argelia Sandoval, Loretta Ehrunmwunsee, Tanyanika Phillips, Ravi Salgia, Amartej Merla, Shanmuga Subbiah, Michelle El-Hajjouie, Jeffrey Staley, Heather Graves, Ranjan Pathak, Shaira Dingal, Sagus Sampath, Beverly Laksana, Thomas Joseph, Tricia Eugenio, Veronica Degoma, Kathleen Burns, Sarah Phillips, Tingting Tan, Kelly Tarkshian, Virginia Sun, Arya Amini, Khristie Davy, Janet Cronkhite, Mary Cianfrocca, Susan Brown, Yuman Fong, Steven Rosen
BACKGROUND: Tobacco control is important for cancer patient health, but delivering effective low-dose CT (LDCT) screening and tobacco cessation is more difficult in underserved and patients from racial and ethnic minority groups. At City of Hope (COH), we have developed strategies to overcome barriers to the delivery of LDCT and tobacco cessation. METHODS: We performed a needs assessment. New tobacco control program services were implemented focusing on patients from racial and ethnic minority groups...
February 6, 2023: Journal of Clinical Medicine
https://read.qxmd.com/read/36729768/implementation-of-pharmacogenomics-into-inpatient-general-medicine
#47
JOURNAL ARTICLE
Thomas Chen, Peter H O'Donnell, Merisa Middlestadt, Gregory W Ruhnke, Keith Danahey, Xander M R van Wijk, Anish Choksi, Randall Knoebel, Seth Hartman, Kiang-Teck Jerry Yeo, Paula N Friedman, Mark J Ratain, Edith A Nutescu, Kevin J O'Leary, Minoli A Perera, David O Meltzer
Pharmacogenomics is a crucial piece of personalized medicine. Preemptive pharmacogenomic testing is only used sparsely in the inpatient setting and there are few models to date for fostering the adoption of pharmacogenomic treatment in the inpatient setting. We created a multi-institutional project in Chicago to enable the translation of pharmacogenomics into inpatient practice. We are reporting our implementation process and barriers we encountered with solutions. This study, 'Implementation of Point-of-Care Pharmacogenomic Decision Support Accounting for Minority Disparities', sought to implement pharmacogenomics into inpatient practice at three sites: The University of Chicago, Northwestern Memorial Hospital, and the University of Illinois at Chicago...
February 1, 2023: Pharmacogenetics and Genomics
https://read.qxmd.com/read/36719510/health-inequity-in-genomic-personalized-medicine-in-underrepresented-populations-a-look-at-the-current-evidence
#48
REVIEW
Sherouk M Tawfik, Aliaa A Elhosseiny, Aya A Galal, Martina B William, Esraa Qansuwa, Rana M Elbaz, Mohamed Salama
Improvements in sequencing technology coupled with dramatic declines in the cost of genome sequencing have led to a proportional growth in the size and number of genetic datasets since the release of the human genetic sequence by The Human Genome Project (HGP) international consortium. The HGP was undeniably a significant scientific success, a turning point in human genetics and the beginning of human genomics. This burst of genetic information has led to a greater understanding of disease pathology and the potential of employing this data to deliver more precise patient care...
January 31, 2023: Functional & Integrative Genomics
https://read.qxmd.com/read/36714036/sex-differences-in-drug-effects-and-or-toxicity-in-oncology
#49
JOURNAL ARTICLE
H T Rakshith, S Lohita, Anvil Preem Rebello, Prakash S Goudanavar, N Raghavendra Naveen
The prevalence, incidence, and severity of a wide variety of diseases and ailments are significantly influenced by the significant disparities that occur between the sexes. The way that men and women react to pharmacological treatment also varies. Therefore, it is crucial to comprehend these reactions in order to conduct risk assessment correctly and to develop safe and efficient therapies. Even from that limited vantage point, the manner and timing of our drug usage might have unintended and unanticipated consequences...
2023: Curr Res Pharmacol Drug Discov
https://read.qxmd.com/read/36643655/disparity-in-the-era-of-personalized-medicine-for-epithelial-ovarian-cancer
#50
REVIEW
Michael-John Devlin, Rowan E Miller
The treatment of high-grade serous ovarian cancer and high-grade endometrioid ovarian cancer has seen significant improvements in recent years, with BRCA1/2 and homologous recombination status guiding a personalized approach which has resulted in improved patient outcomes. However, for other epithelial ovarian cancer subtypes, first-line treatment remains unchanged from the platinum-paclitaxel trials of the early 2000s. In this review, we explore novel therapeutic approaches being adopted in the treatment of clear cell, mucinous, carcinosarcoma and low-grade serous ovarian cancer and the biological rational behind them...
2023: Therapeutic Advances in Medical Oncology
https://read.qxmd.com/read/36613149/gender-and-sex-in-medical-practice-an-exploratory-study-on-knowledge-behavior-and-attitude-among-sicilian-physicians
#51
JOURNAL ARTICLE
Giuseppina Campisi, Fortunato Buttacavoli, Massimo Attanasio, Mirella Milioto, Silvia Radosti, Salvatore Amato, Vera Panzarella
Personalized medicine is a new paradigm in health care, and the concept of socio-cultural gender, as opposed to biological sex, emerged in several medical approaches. This exploratory study aimed to investigate the knowledge of sex and gender in clinical medicine among Sicilian physicians. Data collection was based on an online survey sent to the members of the Medical Councils of Sicily (Italy). The questionnaire included nine specific items about awareness and attitudes regarding gender medicine and its importance in clinical practice...
January 1, 2023: International Journal of Environmental Research and Public Health
https://read.qxmd.com/read/36556244/effect-of-a-nicu-to-home-physical-therapy-intervention-on-white-matter-trajectories-motor-skills-and-problem-solving-skills-of-infants-born-very-preterm-a-case-series
#52
Christiana Dodd Butera, Claire Rhee, Claire E Kelly, Thijs Dhollander, Deanne K Thompson, Jessica Wisnowski, Rebecca M Molinini, Barbara Sargent, Natasha Lepore, Greg Vorona, Dave Bessom, Mary S Shall, Jennifer Burnsed, Richard D Stevenson, Shaaron Brown, Amy Harper, Karen D Hendricks-Muñoz, Stacey C Dusing
Infants born very preterm (VPT; ≤29 weeks of gestation) are at high risk of developmental disabilities and abnormalities in neural white matter characteristics. Early physical therapy interventions such as Supporting Play Exploration and Early Development Intervention (SPEEDI2) are associated with improvements in developmental outcomes. Six VPT infants were enrolled in a randomised clinical trial of SPEEDI2 during the transition from the neonatal intensive care unit to home over four time points. Magnetic resonance imaging scans and fixel-based analysis were performed, and fibre density (FD), fibre cross-section (FC), and fibre density and cross-section values (FDC) were computed...
December 7, 2022: Journal of Personalized Medicine
https://read.qxmd.com/read/36454130/toward-a-more-just-system-of-care-in-molecular-pathology
#53
JOURNAL ARTICLE
Cullen M Lilley, Minerve Delille, Kamran M Mirza, Megan Parilla
UNLABELLED: Policy Points American health care policy must be critically assessed to establish the role it plays in sustaining and alleviating the health disparities that currently exist in molecular genetic testing. It is critical to understand the economic and sociocultural influences that drive patients to undergo or forgo molecular testing, especially in marginalized patient populations. A multipronged solution with actions necessary from multiple stakeholders is required to reduce the cost of health care, rebalance regional disparities, encourage physician engagement, reduce data bias, and earn patients' trust...
December 2022: Milbank Quarterly
https://read.qxmd.com/read/36423203/diversity-equity-and-inclusion-in-clinical-research-a-path-towards-precision-health-for-everyone
#54
REVIEW
Vindell Washington, Joseph B Franklin, Erich S Huang, Jessica L Mega, Amy Abernethy
Healthcare disparities are a persistent societal problem. One of the contributing factors to this status quo is the lack of diversity and representativeness of research efforts, which result in non-generalizable evidence that, in turn, provides suboptimal means to enable the best possible outcomes at the individual level. There are several strategies that research teams can adopt to improve the diversity, equity and inclusion (DEI) of their efforts; these strategies span the totality of the research path, from initial design to the shepherding of clinical data through a potential regulatory process...
November 24, 2022: Clinical Pharmacology and Therapeutics
https://read.qxmd.com/read/36407451/cardio-oncology-digital-innovations-precision-medicine-and-health-equity
#55
REVIEW
Diego Sadler, Tochukwu Okwuosa, A J Teske, Avirup Guha, Patrick Collier, Rohit Moudgil, Abdullah Sarkar, Sherry-Ann Brown
The rapid emergence of cardio-oncology has resulted in a rapid growth of cardio-oncology programs, dedicated professional societies sections and committees, and multiple collaborative networks that emerged to amplify the access to care in this new subspecialty. However, most existing data, position statements and guidelines are limited by the lack of availability of large clinical trials to support these recommendations. Furthermore, there are significant challenges regarding proper access to cardio-oncology care and treatment, particularly in marginalized and minority populations...
2022: Frontiers in Cardiovascular Medicine
https://read.qxmd.com/read/36360466/fighting-cancer-around-the-world-a-framework-for-action
#56
JOURNAL ARTICLE
Denis Horgan, Rizwana Mia, Tosan Erhabor, Yosr Hamdi, Collet Dandara, Jonathan A Lal, Joel Fokom Domgue, Oladimeji Ewumi, Teresia Nyawira, Salomé Meyer, Dominique Kondji, Ngiambudulu M Francisco, Sadakatsu Ikeda, Chai Chuah, Roselle De Guzman, Anupriya Paul, Krishna Reddy Nallamalla, Woong-Yang Park, Vijay Tripathi, Ravikant Tripathi, Amber Johns, Mohan P Singh, Maude E Phipps, France Dube, Kate Whittaker, Deborah Mukherji, Hadi Mohamad Abu Rasheed, Marta Kozaric, Joseph A Pinto, Stephen Doral Stefani, Federico Augustovski, Maria Eugenia Aponte Rueda, Ricardo Fujita Alarcon, Hugo A Barrera-Saldana
Tackling cancer is a major challenge right on the global level. Europe is only the tip of an iceberg of cancer around the world. Prosperous developed countries share the same problems besetting Europe-and the countries and regions with fewer resources and less propitious conditions are in many cases struggling often heroically against a growing tide of disease. This paper offers a view on these geographically wider, but essentially similar, challenges, and on the prospects for and barriers to better results in this ceaseless battle...
October 25, 2022: Healthcare (Basel, Switzerland)
https://read.qxmd.com/read/36339196/rare-disease-emerging-as-a-global-public-health-priority
#57
REVIEW
Claudia Ching Yan Chung, Annie Tsz Wai Chu, Brian Hon Yin Chung
The genomics revolution over the past three decades has led to great strides in rare disease (RD) research, which presents a major shift in global policy landscape. While RDs are individually rare, there are common challenges and unmet medical and social needs experienced by the RD population globally. The various disabilities arising from RDs as well as diagnostic and treatment uncertainty were demonstrated to have detrimental influence on the health, psychosocial, and economic aspects of RD families. Despite the collective large number of patients and families affected by RDs internationally, the general lack of public awareness and expertise constraints have neglected and marginalized the RD population in health systems and in health- and social-care policies...
2022: Frontiers in Public Health
https://read.qxmd.com/read/36294701/five-year-cardiovascular-outcomes-after-infective-endocarditis-in-patients-with-versus-without-drug-use-history
#58
JOURNAL ARTICLE
Brandon Muncan, Alan Abboud, Aikaterini Papamanoli, Mark Jacobs, Allison J McLarty, Hal A Skopicki, Andreas P Kalogeropoulos
BACKGROUND: Disparities in treatment and outcomes of infective endocarditis (IE) between people who use drugs (PWUD) and non-PWUD have been reported, but long-term data on cardiovascular and cerebrovascular outcomes are limited. We aim to compare 5-year rates of mortality, cardiovascular and cerebrovascular events after IE between PWUD and non-PWUD. METHODS: Using data from the TriNetX Research Network, we examined 5-year cumulative incidence of mortality, myocardial infarction, heart failure, atrial fibrillation/flutter, ventricular tachyarrhythmias, ischemic stroke, and intracranial hemorrhage in 7132 PWUD and 7132 propensity score-matched non-PWUD patients after a first episode of IE...
September 22, 2022: Journal of Personalized Medicine
https://read.qxmd.com/read/36272690/a-novel-approach-to-reducing-disparities-in-health-outcomes-by-enhancing-interpretation-of-cancer-clinical-trials-for-underrepresented-patient-groups
#59
REVIEW
Sean Khozin, Roger M Stein
There has been a growing realization, based on emerging evidence from the point of care, that real-world outcomes of patients with cancer are often inferior to those reported in conventional clinical trials. This phenomenon can be attributed in part to deficits in external validity that are present in many studies. Several factors contribute to external validity deficits, including narrow eligibility criteria, differences between protocol-specified procedures and routine care, and inadequate access to clinical trial participation among underrepresented and socioeconomically disadvantaged groups...
October 19, 2022: Biochimica et Biophysica Acta. Reviews on Cancer
https://read.qxmd.com/read/36250524/helping-the-science-speak-for-itself-lessons-learned-developing-video-summaries-for-a-precision-medicine-and-health-disparities-collaborative
#60
JOURNAL ARTICLE
Jennifer V Chavez, David Crenshaw, Sunil Kripalani, Carolyn Szetela, Marino A Bruce, Rosario Isasi, Victoria Behar-Zusman
Skills to effectively communicate research findings are important to expand meaningful inclusion of the public in research, but attempts to summarize findings may be challenging given increasing reliance on succinct communications. Led by our Ethics Advisory Board and within the context of our work with the Precision Medicine and Health Disparities Collaborative, we decided to engage in the iterative process of developing video summaries. Our stakeholders taught us to incorporate novel strategies to engage broader audiences, leading to the production of two video summaries, a public summary toolbox and an adapted process for developing video summaries...
October 17, 2022: Personalized Medicine
keyword
keyword
104206
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.